
PhoreMost
@phoremostltd
PhoreMost is a new-model drug discovery company dedicated to ‘Drugging the Undruggable®’
PhoreAll and PhoreEST are our dedicated inclusion & green initiatives.
ID: 824195150897381377
http://www.PhoreMost.com 25-01-2017 10:00:11
537 Tweet
649 Followers
328 Following

💡 A brilliant idea for helping cancer patients is just an idea until it's put into practice. Here, Cambridge University explores 10 of its spinouts #ChangingTheStoryOfCancer, including PhoreMost, by developing more effective and targeted oncology therapies: tinyurl.com/23etgn8n



“The next decade promises further innovation in the rational design of molecular glues” In a recent article with The Medicine Maker, Dr Ben Cross explored how innovations in MGDs will overcome limitations of other degraders, improving therapeutic outcomes. 📰tinyurl.com/2bhs7b9y


Dr Neil Torbett and Dr Ian Hutchison are at #BIOEurope, meeting with leaders from life sciences to discuss the latest opportunities for collaborative innovation. Interested in learning how we are enabling discovery of degrader therapeutics? Get in touch: [email protected]



Our team is back from a busy week at #BIOEurope! Didn’t manage to schedule a meeting with us in person? Get in touch during the online digital partnering event to learn more about how we’re enabling the discovery of novel degrader therapeutics: [email protected]


Founded as a spinout from Cambridge University and supported by its innovation arm Cambridge Enterprise, we are pioneering new technologies to identify druggable targets. Read this case study to learn more about our story: shorturl.at/bg1hY


Our team is in London for the 15th edition of #MedicineAtTheCrick! Hosted by The Francis Crick Institute, today’s symposium explores new frontiers in drug discovery. Get in touch ➡️ phoremost.com/contact


Dr Benedict Cross spoke with The Medicine Maker, sharing his insights into innovations in molecular glues and how they can improve therapeutic outcomes by drugging the undruggable. 📰 If you haven’t already, read the full article here: lnkd.in/ecQSjFuE








Two months after @ELRIG_UK Drug Discovery, it’s great to see the conversations and insights continuing! Check out our poster “Uncovering New Pathways for Targeted Protein Degradation" on News Medical: tinyurl.com/2bmzhs66 #TPD #DegraderTherapeutics


